Next gen sequencing
FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status in patients with ovarian cancer
Interpretive report provided
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
14 - 21 days
There are test kits supplied by the company to be used for shipping the block/slides. Sendouts only has 1 in stock, please contact the company to order kits if needed.
Test performed by Myriad Genetics- Oncology